ASK1 activation in glial cells in post‐mortem multiple sclerosis tissue
Neuropathology · 2025
DOI: 10.1111/neup.12978 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neuropathology, 2025. Verfasst von Erika Seki und 6 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Molecular Pathology and Histology, Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan. Hauptthemen laut MEDLINE: MAP Kinase Kinase Kinase 5, Multiple Sclerosis, Neuroglia, Brain. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben. Gefördert von: Japan Society for the Promotion of Science (JSPS) KAKENHI Grants-in-Aid for Scientific Research, Shiseido Female Researcher Science, Japan Society for the Promotion of Science.
Abstract (Originalsprache)
Multiple sclerosis (MS), the leading cause of disability in young adults, is an inflammatory disease of the central nervous system characterized by localized areas of demyelination. Apoptosis signal‐regulating kinase 1 (ASK1) is a mitogen‐activated protein kinase kinase kinase that has been shown to be implicated in the pathogenesis of experimental autoimmune encephalomyelitis (EAE), a mouse model of MS. Interestingly, ASK1 signaling regulates glial cell interactions and drives neuroinflammation in EAE mice. To further investigate its clinical significance, in the present study, we examined the activation of ASK1 in the post‐mortem brain of MS patients. ASK1 activation was found in active lesions of the corpus callosum in both microglia/macrophages and astrocytes. Moreover, ASK1 activation in astrocytes was higher than that in microglia/macrophages, which was in line with our findings in EAE mice. Our results suggest an important role of ASK1 in glial cells, indicating that ASK1 might be a good therapeutic target for MS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Molecular Pathology and Histology, Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan.
- Visual Research Project, Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan.
- Department of Laboratory Medicine and Pathology (Neuropathology), Tokyo Metropolitan Neurological Hospital, Tokyo, Japan.
- Department of Pathology, Yokohama Municipal Citizen's Hospital, Kanagawa, Japan.
ORCID-Profile: Erika Seki, Xiaoli Guo
Förderung
- Japan Society for the Promotion of Science (JSPS) KAKENHI Grants-in-Aid for Scientific Research
- Shiseido Female Researcher Science
- Japan Society for the Promotion of Science
Zitieren
APA
Seki, E., Guo, X., Namekata, K., Komori, T., Hayashi, H., Arai, N., & Harada, T. (2025). ASK1 activation in glial cells in post‐mortem multiple sclerosis tissue. Neuropathology. https://doi.org/10.1111/neup.12978
Vancouver
Seki E, Guo X, Namekata K, Komori T, Hayashi H, Arai N, et al. ASK1 activation in glial cells in post‐mortem multiple sclerosis tissue. Neuropathology. 2025. doi:10.1111/neup.12978
BibTeX
@article{Seki2025,
author = {Seki, Erika and Guo, Xiaoli and Namekata, Kazuhiko and Komori, Takashi and Hayashi, Hiroyuki and Arai, Nobutaka and Harada, Takayuki},
title = {ASK1 activation in glial cells in post‐mortem multiple sclerosis tissue},
journal = {Neuropathology},
year = {2025},
doi = {10.1111/neup.12978}
}
EUVIMED